投资者关系活动记录表 证券代码：300096 证券简称：易联众 易联众信息技术股份有限公司投资者关系活动记录表 编号：2018-0010 | --- | --- | --- | |-------------------------|--------------------------|------------------------------------------------| | | 特定对象调研 | □ 分析师会议 | | 投资者关系活动类 | □ 媒体采访 | □ 业绩说明会 | | 别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 一对一沟通 | | | □ | 其他（请文字说明其他活动内容） | | 参与单位名称及人 员姓名 | 东北证券 何柄谕 | | | | | | | 时间 | 2018 年 12 月 06 | 日 下午 14:50-15:30 | | 地点 | 易联众公司 | | | 上市公司接待人员 | | 董事会秘书：李虹海 董办专员：周丽 | | 投资者关系活动主 | 会谈内容： | | | 要内容介绍 | | 李总首先对公司的发展历程及主要业务进行了简 ...

投资者关系活动记录表 证券代码：300096 证券简称：易联众 易联众信息技术股份有限公司投资者关系活动记录表 编号：2018-008 | --- | --- | --- | |-------------------------|--------------------------|------------------------------------------------| | | 特定对象调研 | □ 分析师会议 | | 投资者关系活动类 | □ 媒体采访 | □ 业绩说明会 | | 别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 一对一沟通 | | | □ | 其他（请文字说明其他活动内容） | | 参与单位名称及人 员姓名 | | 华创证券：吴璋怡 、上海磐伫资管中心：马超群 | | 时间 | 2018 年 11 月 07 | 日 上午 10:00-10:50 | | 地点 | 易联众公司 | | | 上市公司接待人员 | | 董事会秘书：李虹海 董办专员：周丽 | | 投资者关系活动主 | 会谈内容： | | | 要内容介绍 | | 李总首先对公司的发展历程及主要业务 ...

投资者关系活动记录表 证券代码：300096 证券简称：易联众 易联众信息技术股份有限公司投资者关系活动记录表 编号：2018-009 | --- | --- | --- | |------------------|--------------------------|--------------------------------------------| | | 特定对象调研 | □ 分析师会议 | | 投资者关系活动类 | □ 媒体采访 | □ 业绩说明会 | | 别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 一对一沟通 | | | □ | 其他（请文字说明其他活动内容） | | 参与单位名称及人 | | 海通证券：杨林 中海基金：李东祥 | | 员姓名 | 方正证券：林凯、姜天骄 | | | | 华泰资产：马颖 | | | 时间 | 2018 年 11 月 14 | 日 上午 10:00-11:00 | | 地点 | 易联众公司 | | | 上市公司接待人员 | | 董事会秘书：李虹海 董办专员：周丽 | | 投资者关系活动主 | 会谈内容： | | | 要内容介绍 | ...

投资者关系活动记录表 证券代码：300096 证券简称：易联众 易联众信息技术股份有限公司投资者关系活动记录表 编号：2019-0001 | --- | --- | --- | |------------------|------------------------------|------------------------------------------------| | | 特定对象调研 | □ 分析师会议 | | 投资者关系活动类 | □ 媒体采访 | □ 业绩说明会 | | 别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 一对一沟通 | | | □ | 其他（请文字说明其他活动内容） | | 参与单位名称及人 | 国盛证券：方郁文 | | | 员姓名 | 交银施罗德基金：韩威俊、邱华 | | | 时间 | 2019 年 3 月 13 | 日 下午 14:00-15:00 | | 地点 | 易联众公司 | | | 上市公司接待人员 | | 董事会秘书：李虹海 董事会专员：周丽 | | 投资者关系活动主 | 会谈内容： | | | 要内容介绍 | | 李总首先对公司的发展 ...

投资者关系活动记录表 证券代码：300096 证券简称：易联众 易联众信息技术股份有限公司投资者关系活动记录表 编号：2021-002 | --- | --- | --- | |------------------|----------------------------------|------------------------------------------------| | | □ 特定对象调研 | □ 分析师会议 | | 投资者关系活动类 | □ 媒体采访 | 业绩说明会 | | 别 | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | □ 一对一沟通 | | | □ 其他 | | | 参与单位名称及人 | 通过"易联众投资者关系"小程序举办 | 2020 年度网上 | | 员姓名 | 业绩说明会。 | | | 时间 | 2021 年 05 月 10 日 | 下午 15:00-17:00 | | | | 本次年度网上业绩说明会采用网络远程平台的方式举 | | 地点 | | 行，投资者通过"易联众投资者关系"小程序参与互动 | | | 交流。 | | | | 董事长：张曦先生 | | ...

Company Overview - Established in 2000, the company focuses on information technology in healthcare, social security, and human resources, covering over 20 provinces and more than 100 cities, serving over 3,000 hospitals and nearly 20,000 grassroots medical institutions [1][2]. Innovation and Achievements - The company has pioneered several industry-firsts, including: - 2006: First to achieve provincial medical insurance interconnection and real-time settlement for cross-regional medical treatment [2]. - 2012: Launched the first cloud computing platform for public service in the country [2]. - 2016: Became the main contractor for the provincial medical insurance information system in Fujian [2]. - 2020: First to implement online hospital applications integrating medical insurance electronic certificates and health cards [2]. Business Areas Medical Security - The core business includes the construction of medical insurance information systems, supporting government and social multi-level medical security service needs [4][5]. - The company has accumulated extensive experience in medical insurance information technology, becoming the largest contractor for the National Medical Insurance Bureau's information platform project in 2019 [3][5]. Health Medical Services - The company expands into public health services and internet medical fields, providing comprehensive health information services covering disease prevention, treatment, and health management [6][7]. - Products include regional health solutions, health big data applications, and smart hospital solutions [7]. Livelihood Services - Focuses on providing integrated solutions for government departments, including social insurance, labor employment, and human resources [8]. - The company has developed a public service platform and a social security card management platform, covering over ten provinces [8][9]. Payment Solutions - Aims to optimize payment processes across various sectors, including healthcare and social security, through the development of multiple payment platforms [9][10]. - Successfully implemented payment solutions in several provinces, enhancing user experience [9]. Future Plans - The company plans to enhance its service offerings in healthcare, social security, and livelihood services, aiming to become a data-driven technology and service enterprise [12][13]. - It seeks to build a comprehensive operational service model that integrates online and offline services, leveraging its experience in national-level digital ecosystem construction [12][13].

投资者关系活动记录表 证券代码：300096 证券简称：易联众 易联众信息技术股份有限公司投资者关系活动记录表 编号：2021-006 | --- | --- | --- | |------------------|------------------------------|-------------------------------------------------------------------------------------------| | | | □特定对象调研 □分析师会议 | | | | □媒体采访 □业绩说明会 | | 投资者关系活动类 | □新闻发布会 | □路演活动 | | 别 | □现场参观 | □ 一对一沟通 | | | 其他 2021 | 年度厦门辖区上市公司投资者网上集体接待日活 | | | 动 | | | 参与单位名称及人 | | 通过全景网"投资者关系互动平台"参与"2021年度厦门辖区 | | 员姓名 | | 上市公司投资者网上集体接待日"活动的投资者 | | 时间 | 2021 年 9 月 7 日 | 下午 15:00-17:00 | | 地点 | （ htt ...

Financial Performance - The company's revenue for Q3 2022 was ¥122,960,024.82, a decrease of 30.31% compared to the same period last year[4] - The net profit attributable to shareholders was -¥56,645,243.59, representing a decline of 112.64% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥60,445,238.84, down 87.14% from the previous year[4] - Total operating revenue for Q3 2022 was CNY 297.20 million, a decrease of 31.2% compared to CNY 432.41 million in the same period last year[25] - Net loss for Q3 2022 was CNY 232.90 million, compared to a net loss of CNY 136.01 million in Q3 2021, representing an increase in loss of 71.4%[26] - The total comprehensive income for Q3 2022 was -258,087,290.28 CNY, compared to -139,796,719.54 CNY in the same period last year, indicating a significant decline[27] Assets and Liabilities - Total assets at the end of Q3 2022 were ¥1,516,217,717.91, a decrease of 9.21% from the end of the previous year[4] - Total assets decreased to CNY 1.52 billion, down 9.2% from CNY 1.67 billion at the end of the previous year[22] - Total liabilities increased to CNY 996.56 million, up 11.2% from CNY 896.42 million year-on-year[23] - The company's total current assets decreased from RMB 254,135,962.85 at the beginning of the year[20] Cash Flow - The operating cash flow net amount for the year-to-date was -¥209,052,441.01, an increase of 21.31% compared to the previous year[4] - The net cash flow from operating activities was -209,052,441.01 CNY, an improvement from -265,657,902.39 CNY year-over-year[30] - The net cash flow from investing activities was -16,038,659.97 CNY, a decline from a positive cash flow of 65,905,266.39 CNY in the previous year[30] - The net cash flow from financing activities was 30,287,324.41 CNY, compared to a negative cash flow of -76,414,084.14 CNY in the same period last year, showing a recovery[31] Shareholder Information - Total number of common shareholders at the end of the reporting period is 30,244[13] - Zhang Xi holds 16.21% of shares, totaling 69,681,649 shares, with 65,938,125 shares pledged[13] - WeDoctor Holdings Limited owns 9.58% of shares, amounting to 41,200,000 shares[14] - Tibet Wuwei Asset Management Co., Ltd. holds 5.00% of shares, totaling 21,499,900 shares[14] Operational Changes - The company has undergone changes in its supervisory board and securities affairs representative[18] - The company plans to focus on expanding its market presence and enhancing product development in the upcoming quarters[26] - The company is exploring potential mergers and acquisitions to strengthen its competitive position in the market[26] Inventory and Expenses - The company's inventory increased by 61.79% to ¥236,138,799.23 due to the rise in contract performance costs and goods dispatched[8] - Research and development expenses increased to CNY 154.64 million, up 10.9% from CNY 139.46 million in the previous year[26] Earnings Per Share - The company's basic and diluted earnings per share were both -¥0.1317, a decrease of 112.47% year-on-year[4] - Basic and diluted earnings per share were both -0.4213 CNY, worsening from -0.2442 CNY in the previous year[27]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥174,237,893, a decrease of 31.93% compared to ¥255,978,662.62 in the same period last year [24]. - The net loss attributable to shareholders for the first half of 2022 was ¥124,526,887.83, which is a 58.88% increase in loss compared to ¥78,376,720.20 in the previous year [24]. - The basic and diluted earnings per share for the first half of 2022 were both -¥0.2896, a decline of 58.86% from -¥0.1823 in the previous year [24]. - The weighted average return on net assets was -22.29%, compared to -11.59% in the same period last year, indicating a worsening financial performance [24]. - The total comprehensive loss for the first half of 2022 was -¥179,711,088.91, compared to -¥106,596,762.76 in the first half of 2021 [180]. - The company reported a significant increase in management expenses to ¥111,582,180.51, up from ¥103,970,335.05 in the previous year, indicating a rise of 7.8% [177]. - The net cash flow from operating activities improved by 26.63%, amounting to -¥202,922,140.48, compared to -¥276,570,704.48 in the same period last year [24]. - The company reported a total revenue of approximately 210.23 million for the first half of 2022, with a net profit of around 49.01 million, reflecting a significant growth compared to the previous period [94]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,550,033,291.44, reflecting a decrease of 7.19% from ¥1,670,098,071.00 at the end of the previous year [24]. - The net assets attributable to shareholders decreased by 21.86%, from ¥627,210,219.79 to ¥490,125,876.78 [24]. - The company's cash and cash equivalents decreased significantly from ¥254,135,962.85 to ¥92,605,024.96, indicating a reduction of about 63.6% [170]. - Total liabilities increased from CNY 896,422,764.68 to CNY 952,724,718.92, an increase of about 6.3% [172]. - The company's long-term equity investments decreased by 8.59% to ¥345,215,653 from ¥377,790,116 year-on-year [79]. - The total amount of retained earnings at the end of the current period was CNY 490,125,876 [196]. Cash Flow - The net cash flow from operating activities was -¥202,922,140.48, an improvement from -¥276,570,704.48 in the previous period, indicating a reduction in cash outflow [186]. - The total cash inflow from financing activities increased to ¥172,085,500.00, compared to ¥88,043,300.00 in the prior period, reflecting stronger financing efforts [187]. - The cash flow from investment activities was significantly lower, with cash inflow of ¥6,531,506.89 compared to ¥71,330,478.86 in the previous period, reflecting reduced asset disposals [186]. Strategic Focus and Innovations - The company is focusing on digital transformation driven by new infrastructure technologies such as 5G, cloud computing, big data, artificial intelligence, IoT, and blockchain [32]. - The company is actively involved in the development of a digital government service system, leveraging new technologies for comprehensive public service [36]. - The company has launched innovative payment solutions for various hospitals, enhancing the efficiency of medical payment processes [39]. - The company has introduced new technologies, including AI and blockchain, to enhance its service offerings and operational efficiency [41]. - The company is focusing on expanding its market presence through innovative healthcare solutions and strategic partnerships [54]. Risk Management - The management emphasizes the importance of risk awareness regarding forward-looking statements and potential operational risks [3]. - The report includes a detailed description of the company's risks and countermeasures in the management discussion section [3]. - The company has a comprehensive risk management strategy in place to address potential market and policy risks that could impact its business operations [96]. Corporate Governance and Shareholder Matters - The company plans not to distribute cash dividends, issue bonus shares, or increase share capital from reserves [4]. - The company has maintained a stable profit distribution policy to ensure reasonable returns to investors [112]. - The company completed a share transfer of 25% equity in a subsidiary, generating a transaction price of ¥3,875,000, with a net profit contribution of ¥119,800 [90]. - The company has implemented a share repurchase program, but specific details on the progress are not disclosed [151]. Social Responsibility and Community Engagement - The company has actively engaged in social responsibility initiatives, including purchasing local agricultural products to support poverty alleviation efforts [114]. - The company aims to enhance public health service capabilities and ensure people's health through the promotion of smart hospitals and medical communities [35].

Financial Performance - The company's revenue for Q1 2022 was ¥72,422,850.80, representing a slight increase of 0.08% compared to ¥72,362,291.17 in the same period last year[2] - The net profit attributable to shareholders was -¥69,430,631.97, a decrease of 22.36% from -¥56,743,247.14 year-on-year[2] - The basic and diluted earnings per share were both -¥0.1615, a decrease of 24.23% from -¥0.1300 in the same period last year[2] - Net loss for Q1 2022 was CNY 92,100,064.17, compared to a net loss of CNY 73,273,233.34 in the same period last year[24] - The company reported a comprehensive loss of CNY 122,287,694.30, up from a loss of CNY 80,683,905.19 in the previous year[24] Cash Flow - The net cash flow from operating activities was -¥181,576,490.07, which is a decline of 12.75% compared to -¥161,036,894.15 in the previous year[2] - Cash inflow from operating activities totaled CNY 152,170,009.37, down from CNY 178,750,376.59 in the prior period[26] - The company reported a net decrease in cash and cash equivalents of 112,093,888.79 CNY, compared to a decrease of 81,864,470.09 CNY in the prior period[27] - Cash flow from investing activities decreased by 82.98%, primarily due to the previous year's receipt of funds from the sale of a subsidiary[8] - The cash outflow for investment activities totaled 2,448,784.64 CNY, compared to 1,146,681.50 CNY in the previous period[27] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,532,381,086.40, down 8.25% from ¥1,670,098,071.00 at the end of the previous year[2] - The company's equity attributable to shareholders decreased by 15.86% to ¥527,707,111.10 from ¥627,210,219.79 at the end of the previous year[2] - The company’s total liabilities decreased to CNY 882,667,119.27 from CNY 896,422,764.68[21] - The company reported a total current liabilities of RMB 1,000,000,000.00, with short-term borrowings increasing to RMB 174,258,333.35 from RMB 105,162,789.54, an increase of about 65.7%[20] Expenses - Total operating costs increased to CNY 177,246,252.87 from CNY 153,497,372.53, with significant rises in sales expenses (CNY 29,363,508.04) and management expenses (CNY 52,611,169.77)[22] - The company reported a 68.46% increase in selling expenses, attributed to the hiring of additional sales personnel and increased sales efforts[6] - Research and development expenses for the quarter were CNY 50,425,959.72, an increase from CNY 45,551,652.83 in the previous year[22] Investments and Financing - The company completed the transfer of 25% equity in Fujian Xingmin Zhili Technology Co., Ltd., receiving a total of RMB 3.875 million[16] - The company also transferred 51% equity in Fujian Yilianzhong Electronic Technology Co., Ltd., receiving RMB 4.46873 million[16] - The company applied for a comprehensive credit facility of RMB 100 million from Xingye Bank, secured by properties and guarantees from the controlling shareholder[15] - The total cash inflow from financing activities was 155,052,500.00 CNY, an increase from 85,145,000.00 CNY in the prior period[27] Inventory and Receivables - The company reported a decrease in inventory from RMB 185,801,436.19 to RMB 145,958,038.15, a reduction of approximately 21.43%[19] - Accounts receivable stood at RMB 245,551,978.34, down from RMB 253,832,894.46, indicating a decrease of approximately 3.24%[19] Other Information - The company did not conduct an audit for the first quarter report[28] - The report was published by the Board of Directors on April 27, 2022[30] - The company received government subsidies during the quarter, with specific amounts disclosed in related announcements[15]